Bronson Crouch
Net worth: 1 M $ as of 2026-05-30
Net worth: 1 M $ as of 2026-05-30
Bronson Crouch is currently Chairman & Chief Executive Officer at Instil Bio, Inc. since 2018.
Mr. Crouch is Managing Partner at Peloton Therapeutics, Inc. and TCR² Therapeutics, Inc. Mr. Crouch is Founding Partner at Curative Ventures Management LLC since 2014.
Formerly, Mr. Crouch was Managing Partner at CoStim Pharmaceuticals, Inc. and iTeos Therapeutics, Inc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
INSTIL BIO, INC. 1.87% | 2026-04-12 | 126,893 ( 1.87% ) | 1 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| INSTIL BIO, INC. | Chief Executive Officer | 2018-10-31 |
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | - |
| PELOTON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare technologies sector. It provides financing for early stage capital requirements | Private Equity Investor | 2013-12-31 |
| Companies | Position | End |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Peloton Therapeutics, Inc.
Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare technologies sector. It provides financing for early stage capital requirements | Finance |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Select your edition
All financial news and data tailored to specific country editions